n.achebe

TL2 Moderator · Verona

Contributes reviews on supplier material. Based in Verona.

Joined 24 December 2024 · last posted 5d

78 posts, newest first. Showing up to 150.

Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #55 · Analytics › Home & field testing · 23 Jul 2026 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #7 · Practice › Administration · 15 Jul 2026 · 7 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Follow-up: How compounding permissions changed when supply normalised Replied, post #11 · Sourcing › Regulatory · 11 Jul 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #67 · Analytics › Impurities & related substances · 11 Jul 2026 · 29 likes On post #63 — agreed on the reasoning, with one qualification. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite…
Pages past their review date, listed — does this still hold? Replied, post #31 · Meta › Wiki maintenance · 30 Jun 2026 · 5 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
Mobile reading experience on long topics Replied, post #2 · Meta › Site feedback · 24 Jun 2026 · 19 likes the opening post answers the question as asked. The question underneath it is different. Moderation decisions: if you disagree with a moderation decision, raising it…
An appeal that succeeded, with the letter structure Replied, post #10 · Access › Insurance & coverage · 22 Jun 2026 · 0 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
Pooling trials with different estimands Replied, post #31 · Evidence › Meta-analyses · 17 Jun 2026 · 25 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
Primary endpoint hierarchies and why order matters — one year on Replied, post #16 · Evidence › Trials · 15 Jun 2026 · 3 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
Journal club: what we got wrong in an earlier session Started this topic · Evidence › Journal club · 11 Jun 2026 · 13 likes On the subject in the title: Journal club: what we got wrong in an earlier session Working notes rather than a conclusion. Session topic: SURMOUNT-1 ( N Engl J Med ,…
Does dual agonism explain the effect size, or is it dose? Replied, post #23 · Compounds › Tirzepatide · 8 Jun 2026 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #26 · Evidence › Journal club · 24 May 2026 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #135 · Compounds › Tirzepatide · 22 May 2026 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Osteoarthritis and mechanical versus metabolic improvement Started this topic · Clinical › Comorbidities · 13 May 2026 · 5 likes Osteoarthritis and mechanical versus metabolic improvement Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population…
A single out-of-range value on an otherwise normal panel Replied, post #43 · Clinical › Bloodwork · 6 May 2026 · 21 likes This follows post #40 rather than contradicting it. Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed…
Transporting a vial for a weekend away — a second dataset Replied, post #44 · Practice › Storage & stability · 4 May 2026 · 2 likes post #43 answers the question as asked. The question underneath it is different. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles,…
List price versus negotiated price versus what you pay Replied, post #107 · Access › Pricing · 17 Apr 2026 · 4 likes Worth separating two things that post #103 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Revisiting: Theoretical plates: useful number or ritual? Replied, post #2 · Analytics › HPLC & UHPLC · 9 Apr 2026 · 16 likes This is why a purity figure without the underlying chromatogram is weaker evidence than it appears. It is also why two competent laboratories can report different…
Spike-and-recover accuracy for a peptide assay Replied, post #42 · Analytics › Method validation · 8 Apr 2026 · 0 likes On post #38 — agreed on the reasoning, with one qualification. Stability-indicating method: one that can separate a compound from its degradation products. Critical for…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #75 · Practice › Interactions · 26 Mar 2026 · 1 like Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
The lowest dose that does anything: is that a real question? Replied, post #85 · Practice › Dosing & titration · 6 Mar 2026 · 10 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
The lowest dose that does anything: is that a real question? Replied, post #64 · Practice › Dosing & titration · 5 Mar 2026 · 12 likes The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #12 · Research Methods › N-of-1 designs · 24 Feb 2026 · 0 likes post #11 answers the question as asked. The question underneath it is different. Objective versus subjective measures: subjective measures (how you feel) are vulnerable…
Cost per delivered dose, which is the number that matters Replied, post #51 · Access › Pricing · 24 Feb 2026 · 18 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #105 · Clinical › Special populations · 19 Feb 2026 · 2 likes Picking up post #102: that is the part I would want checked first. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #29 · Outcomes › Body composition · 18 Feb 2026 · 25 likes post #28 answers the question as asked. The question underneath it is different. Comparison to published data: the trials reported mean fat and lean mass changes.…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #27 · Data & Tools › Datasets · 17 Feb 2026 · 33 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #5 · Sourcing › Red flags · 11 Feb 2026 · 10 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
Oral semaglutide bioavailability and its variability between people Replied, post #34 · Compounds › Oral incretins · 11 Feb 2026 · 18 likes Oral bioavailability is variable between people. Some people absorb well; others absorb poorly. That inter-individual variation is larger than with injectables and is…
Reading SURMOUNT-1 without the press release — one year on Replied, post #46 · Compounds › Tirzepatide · 10 Feb 2026 · 32 likes post #45 answers the question as asked. The question underneath it is different. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
Second pass at: Submitting a sample: the process end to end Replied, post #5 · Sourcing › Independent verification · 28 Jan 2026 · 10 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #117 · Clinical › Special populations · 27 Jan 2026 · 25 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
Aggregates and why a purity assay may miss them entirely Replied, post #49 · Analytics › Impurities & related substances · 4 Jan 2026 · 16 likes I read post #47 twice before replying, because I had assumed the opposite. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the…
Waist circumference technique and its repeatability Replied, post #30 · Outcomes › Progress reports · 23 Dec 2025 · 8 likes Menstrual cycle: for people who menstruate, weight can shift by several pounds across the cycle due to fluid retention and other factors. Noting cycle phase when…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #5 · Outcomes › Body composition · 22 Dec 2025 · 31 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #12 · Sourcing › Red flags · 11 Dec 2025 · 0 likes Coming back to post #10, because the follow-up matters more than the original answer. Evasion when asked: if a supplier does not clarify when asked specifically for…
Prescription requirements and telehealth models Replied, post #59 · Sourcing › Regulatory · 10 Dec 2025 · 9 likes post #58 answers the question as asked. The question underneath it is different. Primary documents matter: regulatory positions are published in official documents.…
Robustness: the parameters worth deliberately varying Replied, post #54 · Analytics › Method validation · 10 Dec 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Can a home kit substitute for a laboratory report? A careful no Replied, post #71 · Analytics › Home & field testing · 6 Dec 2025 · 1 like Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #95 · Compounds › Other compounds · 26 Nov 2025 · 0 likes On post #91 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
Request: export my own posts — one year on Replied, post #9 · Meta › Feature requests · 4 Nov 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Specification in the result column: why that is a meaningful error Replied, post #64 · Analytics › COA interpretation · 27 Oct 2025 · 9 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
Amylin receptor signalling and satiety Replied, post #4 · Pharmacology › Receptor biology · 20 Oct 2025 · 7 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
A parcel that arrived warm: a decision process, not a verdict Replied, post #75 · Practice › Storage & stability · 9 Oct 2025 · 2 likes Picking up post #72: that is the part I would want checked first. Freeze-thaw: some peptide solutions tolerate freezing poorly because ice crystals damage protein…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #9 · Compounds › Cagrilintide & amylin analogues · 30 Sep 2025 · 0 likes Coming back to post #7, because the follow-up matters more than the original answer. Amylin signalling is distinct from GLP-1 signalling. Amylin slows gastric emptying…
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #49 · Analytics › HPLC & UHPLC · 27 Aug 2025 · 23 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Multiplicity when you track fifteen variables Replied, post #3 · marked as the solution · Research Methods › Statistics · 20 Aug 2025 · 20 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
Micronutrient status when intake falls substantially Replied, post #23 · Clinical › Bloodwork · 9 Aug 2025 · 1 like HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
Impurity thresholds: where the common numbers come from — what changed since Started this topic · Analytics › Impurities & related substances · 19 Jul 2025 · 13 likes Posting this under the heading it deserves: Impurity thresholds: where the common numbers come from — what changed since Everything below is what sits behind that. A…
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #21 · Compounds › Secretagogues & GH axis · 3 Jul 2025 · 12 likes What a well-designed human trial of a secretagogue would look like: randomised, placebo-controlled, adequate sample size, IGF-1 as primary outcome, muscle and strength…
Coming back to: What published stability data actually covers, and what it does not Replied, post #64 · Practice › Storage & stability · 15 Jun 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Coming back to: Getting a referral rather than a refusal Replied, post #55 · Clinical › Prescriber conversations · 11 Jun 2025 · 1 like Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
DXA precision and the least significant change for lean mass — the long version Replied, post #93 · Outcomes › Body composition · 25 May 2025 · 19 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
DXA precision and the least significant change for lean mass — the long version Replied, post #78 · Outcomes › Body composition · 22 May 2025 · 0 likes Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not reliable for detecting month-to-month changes. Useful for trend over…
The C-cell question: rodent findings and their human context Replied, post #16 · Compounds › Semaglutide · 13 May 2025 · 0 likes This follows post #13 rather than contradicting it. The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no…
Validating a calculator against hand arithmetic — what changed since Replied, post #46 · Data & Tools › Calculators · 2 May 2025 · 27 likes Mass error checking: enter your observed mass and theoretical mass and check whether the difference in ppm is within reasonable bounds for your instrument. Useful…
Follow-up: Documentation that appears only after payment Replied, post #11 · Sourcing › Red flags · 21 Apr 2025 · 4 likes Unresponsiveness: a supplier that does not reply to reasonable requests for documentation or clarification is showing you something about how they operate.
Carryover and the ghost peak from last week's standard Replied, post #47 · Analytics › HPLC & UHPLC · 7 Apr 2025 · 4 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
Retatrutide dose escalation in the published trials Replied, post #94 · Compounds › Retatrutide · 6 Apr 2025 · 4 likes post #93 is right about the mechanism and I think understates the practical bit. Triple agonism: is the effect additive, synergistic, or neither? A phase 2 comparison…
Counter-ion form: the field almost nobody reports — one year on Replied, post #122 · Analytics › COA interpretation · 25 Mar 2025 · 2 likes What fields matter on a certificate: lot number matching the vial, test date, the analytical method stated specifically, the measured result as a number, and the…
Second pass at: Retatrutide mass and identity: what a report should show Replied, post #3 · Compounds › Retatrutide · 13 Mar 2025 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #26 · Practice › Reconstitution · 5 Mar 2025 · 29 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
What SELECT changed about how semaglutide is discussed, and what it did not Replied, post #20 · Compounds › Semaglutide · 24 Feb 2025 · 0 likes post #19 answers the question as asked. The question underneath it is different. Approved indications differ by jurisdiction and change. As of mid-2026 the…
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #11 · Compounds › Cagrilintide & amylin analogues · 17 Feb 2025 · 1 like Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
Validating a method you did not develop — does this still hold? Replied, post #8 · Analytics › Method validation · 13 Feb 2025 · 0 likes Picking up post #5: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
When "no data" is the complete and final answer Replied, post #85 · Compounds › Other compounds · 6 Feb 2025 · 11 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Ipamorelin selectivity claims and where they came from Replied, post #7 · Compounds › Secretagogues & GH axis · 17 Jan 2025 · 5 likes Ipamorelin selectivity claims originate in preclinical characterisation and are reasonably well supported for what they claim: less effect on cortisol and prolactin…
Body image changing more slowly than the body Replied, post #133 · Wellbeing › Mental health · 25 Dec 2024 · 2 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #63 · Evidence › Journal club · 17 Dec 2024 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
[2026 update] New subcategory: rationale and scope Replied, post #39 · Meta › Announcements · 3 Dec 2024 · 0 likes Implementation timeline: announcements include when a change takes effect. Marking the date helps you know whether the change is already in effect.
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #27 · Nutrition & Training › Protein & intake · 29 Nov 2024 · 24 likes Meeting protein targets on suppressed appetite: this is where the practical difficulty lies. Eating more protein when appetite is suppressed is genuinely hard.…
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #115 · Analytics › COA interpretation · 12 Nov 2024 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
Follow-up: Dead volume across syringe and needle combinations Replied, post #53 · Devices › Syringes & needles · 22 Oct 2024 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #59 · Practice › Dosing & titration · 7 Sep 2024 · 17 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #32 · Sourcing › Independent verification · 2 Sep 2024 · 31 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #2 · Practice › Administration · 30 Aug 2024 · 1 like Angle of injection: 90 degrees into pinched tissue ensures subcutaneous placement. It is not always necessary and shallower angles can work, but 90 degrees into a small…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #26 · Evidence › Journal club · 26 Aug 2024 · 0 likes Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
Second pass at: Retatrutide dose escalation in the published trials Replied, post #61 · Compounds › Retatrutide · 20 Jul 2024 · 0 likes I read post #59 twice before replying, because I had assumed the opposite. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist.…